UK Eases Permanent Residency Path for International Researchers

around the world, allowing eligible researchers to apply for Indefinite Leave to Remain (ILR) after just three years under the Global Talent visa route.

The UK government is introducing a more flexible pathway to permanent residency for experienced researchers from 

Under the revised Global Talent visa scheme, more than 100 research-driven commercial organizations—including AstraZeneca and Jaguar Land Rover—will be able to sponsor international researchers through the “endorsed funder” route.

The expansion covers research-intensive organizations across 10 sectors, including life sciences, biotechnology, artificial intelligence, quantum technologies, advanced manufacturing, clean energy and the creative industries.

Among the prominent organizations included in the scheme are AstraZeneca, Jaguar Land Rover, GSK, Genomics England, Wellcome Sanger Institute, IBM, Arm, Oxford Quantum Circuits, the UK Atomic Energy Authority and the National Nuclear Laboratory.

The changes, announced on August 6, open the Global Talent visa’s endorsed funder route to more than 100 additional commercial organizations, bringing the total number of approved organizations to 291.

The government also plans to further expand the Future Technology Research and Innovation Scheme. The program is designed to attract international researchers to the UK to work in priority areas such as artificial intelligence, quantum computing and engineering biology.

UK Business Secretary Jonathan Reynolds said Britain is already one of the world’s most attractive destinations for leading research talent.

He said the expansion would make it easier for innovative companies to recruit internationally renowned researchers and strengthen the UK’s position as a global hub for research and innovation.

Professor Christopher Smith, UK Research and Innovation’s International, Talent and Skills Champion, said the initiative would benefit a wide range of sectors and regions across the country, including pharmaceuticals, artificial intelligence and the creative industries.

The government says the reforms are aimed at strengthening the UK’s research and innovation ecosystem by making it easier for leading international scientists and researchers to build long-term careers in the country.